02/13/2013 - 11:18am

The Food and Drug Administration has given a special, new designation to a cancer drug under development by Johnson & Johnson and Pharmacyclics, the companies said.

02/12/2013 - 4:30pm

Teva Pharmaceutical Industries has added a University of California at Los Angeles medical professor to its board of directors, the Israeli drug maker said.

02/12/2013 - 3:58pm

Unexpected toxicities from prescription drugs that emerge years after regulatory approval may be due to poor medication adherence in clinical trials, according to a new study.

02/12/2013 - 2:44pm

Massachusetts and New Jersey lately have been cracking down on sterile compounding pharmacies alleged to violate safety regulations, but the crackdown may soon go nationwide, predicted a legal firm focused on the matter.

02/12/2013 - 2:17pm

GlaxoSmithKline may be looking to buy a Brazilian drug maker for up to $4 billion, according to published reports.

02/12/2013 - 11:35am

A topical medication made by Galderma Labs for treating melasma of the face is now available in pharmacies, Galderma said.

02/11/2013 - 2:54pm

The Food and Drug Administration declined to approve two insulin products made by Danish drug maker Novo Nordisk, the company said Sunday.

02/11/2013 - 2:30pm

Generic drug maker Impax Labs has settled with Shire Labs over an authorized generic version of a Shire drug for treating attention deficit hyperactivity disorder, Impax said.

02/11/2013 - 12:12pm

A federal judge has ordered a California company and its owner to stop manufacturing and distributing drugs and dietary supplements in domestic commerce until their manufacturing operations comply with the Federal Food, Drug, and Cosmetic Act, the Food and Drug Administration reported.